Engineered Small Extracellular Vesicles as a FGL1/PD‐L1 Dual‐Targeting Delivery System for Alleviating Immune RejectionHsiang‐i Tsai, Hongbo Chen, Xiaofeng Zhu et al.|Advanced Science|2021Cited by 70
TRAF6 enhances PD-L1 expression through YAP1-TFCP2 signaling in melanomaLinglu Wang, Fang Cheng, Xiaoyan Liu et al.|Cancer Letters|2024Cited by 27
PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemiaHsiang‐i Tsai, Hongbo Chen, Yanping Wu et al.|Acta Pharmaceutica Sinica B|2021Cited by 14
Engineered small extracellular vesicles as a FGL1/PD-L1 dual-targeting delivery system for alleviating immune rejectionHsiang‐i Tsai, Hongbo Chen, Yingyi Wu et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 9
TRAF6 modulates PD-L1 expression through YAP1-TFCP2 signaling in melanomaXiaoyan Liu, Fang Cheng, Linglu Wang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1